CLEARSIDE BIOMEDICAL INC's ticker is and the CUSIP is 185063954. A total of 3 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | -23.5% | 15,900 | +3.9% | 0.00% | – |
| Q2 2023 | $17 | +13.3% | 15,300 | +3.4% | 0.00% | – |
| Q1 2023 | $15 | +50.0% | 14,800 | +64.4% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 9,000 | -67.9% | 0.00% | – |
| Q3 2022 | $31,000 | -43.6% | 28,000 | -25.9% | 0.00% | – |
| Q2 2022 | $55,000 | -49.1% | 37,800 | -20.3% | 0.00% | – |
| Q1 2022 | $108,000 | +83.1% | 47,400 | +118.4% | 0.00% | – |
| Q4 2021 | $59,000 | -47.8% | 21,700 | -7.7% | 0.00% | – |
| Q3 2021 | $113,000 | -0.9% | 23,500 | 0.0% | 0.00% | – |
| Q2 2021 | $114,000 | +5600.0% | 23,500 | +234900.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 10 | +66.7% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | +100.0% | 0.00% | – |
| Q2 2020 | $0 | – | 3 | -25.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 4 | -98.8% | 0.00% | – |
| Q4 2019 | $97,000 | +3133.3% | 336 | +808.1% | 0.00% | – |
| Q4 2018 | $3,000 | -91.9% | 37 | -39.3% | 0.00% | – |
| Q3 2018 | $37,000 | -90.8% | 61 | -83.9% | 0.00% | -100.0% |
| Q2 2018 | $404,000 | +10000.0% | 378 | +1203.4% | 0.00% | – |
| Q1 2018 | $4,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 30,000 | $44,000 | 0.00% |
| SIMPLEX TRADING, LLC | 37,800 | $55,000 | 0.00% |